Quantitative but not qualitative flavor recognition impairments in COVID-19 patients.

Immacolata Cristina NettoreElena CantoneGiuseppe PalatucciFabiana FranchiniRufina MaturiMariagiovanna NerilliElio ManzilloMaria FoggiaLuigi MaionePaola UngaroAnnamaria ColaoPaolo Emidio Macchia

Published in: Irish journal of medical science (2021)

Data reported here suggests that a chemosensory impairment is present after SARS-CoV-2 infection, and the modified "flavor test" could be a novel self-administering objective screening test to assess STDs in COVID-19 patients. Clinical trial registration no. NCT04840966; April 12, 2021, retrospectively registered.

Keyphrases

clinical trial
sars cov
respiratory syndrome coronavirus
electronic health record
high resolution
systematic review
big data
study protocol
open label
randomized controlled trial
double blind
deep learning
phase iii